Santhera Pharmaceuticals (0QN1.LSE) Q2 2026 Earnings

28AprConfirmed
Q3 2024
Q2 2025
Q3 2025
Q2 2026
-3.03
-2.28
-1.54
-0.79

Details

Expected EPS
N/A
Actual EPS
-0.7862631641200001
Surprise EPS
-0.79
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (0QN1.LSE) has reported earnings of -0.7862631641200001 per share for Q2 2026.

0 Comments

Share your thoughts